Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

Bernstein analyst Zhihan Ma maintained a Buy rating on Dollar General today and set a price target of $160.00. Ma covers the Consumer Defensive sec...

Dollar General (DG) Receives a Buy from Bernstein

Integrated Diagnostics Holdings (($GB:IDHC)) has held its Q2 earnings call. Read on for the main highlights of the call. Integrated Diagnostics Hol...

Integrated Diagnostics Holdings Signals Strong Growth Ahead

China Dongxiang (Group) Co ( ($HK:3818) ) has shared an announcement. China Dongxiang (Group) Co., Ltd. has despatched a circular to shareholders o...

China Dongxiang Sends Circular on Share Buy-back and Settlement Plans

China Dongxiang (Group) Co ( ($HK:3818) ) has issued an announcement. China Dongxiang (Group) Co., Ltd., a Cayman Islands-incorporated company list...

China Dongxiang Affirms Director’s Suitability After Hong Kong Disciplinary Action

China Dongxiang (Group) Co ( ($HK:3818) ) has issued an announcement. China Dongxiang has called an extraordinary general meeting for 30 September ...

China Dongxiang Calls EGM to Approve Settlement Deeds and Empower Directors

In a report released on September 4, Zhihan Ma from Bernstein maintained a Buy rating on Dollar General, with a price target of $160.00. The compan...

Bernstein Sticks to Its Buy Rating for Dollar General (DG)

Barclays analyst Seth Sigman maintained a Buy rating on Dollar General on September 4 and set a price target of $151.00. The company’s shares close...

Barclays Sticks to Its Buy Rating for Dollar General (DG)

In a report released today, Scot Ciccarelli from Truist Financial maintained a Hold rating on Dollar General, with a price target of $138.00. Cicca...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$237.59	+0.42%	7.97K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$237.59	+0.4%	7.97K
3
4
5
6

DGX

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel